Botanical Health Dispensary

Independent medical cannabis dispensing in Kenilworth

Botanical Health Dispensary is an independent pharmacy based in Kenilworth (United Kingdom) dedicated to the dispensing of medicinal cannabis-derived products. It operates under the company name MHC Dispensary Ltd. and presents itself as one of the country's first independent pharmacies in this field, working within UK legislation and in strict compliance with General Pharmaceutical Council (GPhC) regulations.

The company is defined by a patient-centred approach: it maintains that it understands both medical cannabis and the experience of being a patient or having a family member who is one, and it keeps in touch with the user at every stage of the process. Its allied pharmacy, Leyes Lane Pharmacy, enables it to manage medical cannabis prescriptions and facilitate home delivery nationwide.

How the prescription service works

Patients with a legal private prescription for medical cannabis in the UK are free to choose how to obtain their medication. Botanical Health Dispensary reminds patients that there is no obligation to use only the pharmacy linked to or recommended by their doctor or clinic, so those who have previously used another dispensary can transfer their future and repeat prescriptions to this pharmacy.

The pharmacy team provides clear information about the prescription and guidance on the full range of cannabis-based medical products available in the UK. Dispensing is channelled through Leyes Lane Pharmacy, which also enables prescriptions to be sent to patients across the country.

Available products and brands

Through its allied pharmacy, the company can dispense medical cannabis products from the following manufacturers and brands:

• Althea
• Aurora
• Bedrocan
• Cellen
• Emmac / Rokshaw (Adven range)
• GW Pharma
• Khiron
• Lyphe Group (Noidecs)
• Medcan SA
• Spectrum
• Tilray

Product formulations and the entourage effect

The company's educational material explains that medical cannabis comes from three wild subspecies — Sativa, Indica and Ruderalis — and that it contains more than 140 phytocannabinoids, of which CBD and THC are the most researched. It notes that whole-plant treatments, which combine THC, CBD and minor cannabinoids, produce a better effect than the components separately, a phenomenon known as the entourage effect.

It also distinguishes other forms of cannabis-derived medication: 'isolates', individual compounds such as CBD without the other phytocannabinoids, and 'broad-spectrum' products, which combine CBD and minor cannabinoids but without THC. Formulations are classified according to their THC to CBD ratio:

• Balanced THC:CBD strains: growing medical consensus suggests that a balanced ratio offers the best therapeutic benefits; as well as addressing insomnia, pain and muscle spasms, this ratio is being studied for skin diseases, autism, fibromyalgia and certain types of cancer.
• CBD-dominant strains: used for treatment-resistant epilepsy, anxiety, Crohn's disease, multiple sclerosis, diabetes and colitis. Treatments are often started with these strains when the patient prefers to avoid the psychoactive effect of THC-dominant strains.
• THC-dominant strains: can be beneficial for chronic pain and post-chemotherapy treatment, as they increase appetite and reduce nausea, as well as reducing inflammation and improving muscle control and coordination. Their effects can include euphoria, positive mood and relaxation; the company recommends combining them with CBD to counteract the anxiety they sometimes cause.

The endocannabinoid system and the most common areas of use

The website describes the endocannabinoid system (ECS), discovered in the early 1990s, present in all the body's major organs and essential for the homeostasis of systems such as the central nervous system. According to the material, it influences memory, movement control, pain modulation, nerve growth and plasticity, sleep, appetite, anxiety, social behaviour, the bladder, the intestines, the reproductive system, the heart, the hormonal and metabolic systems and cancer control. Cannabis treatments complement the body's natural circulation of cannabis-like substances.

Among the most common areas of use listed by the company are:

• Pain: inflammation, arthritis, fibromyalgia.
• Nerve conditions: muscle cramps (spasticity), chronic pain.
• Neurological conditions: epilepsy, acquired or traumatic brain injury, multiple sclerosis, Parkinson's disease, spasticity, fatigue.

Dosage is determined individually: each prescription varies according to the patient's condition and symptoms, and the clinician works with them to adjust the dose in the most effective way.

Legal context and track record in the UK

Medical cannabis has been legal in the UK since 1 November 2018, following a campaign in which Hannah Deacon, linked to Botanical Health Dispensary, took part. The company notes that, although to date only three whole-plant cannabis prescriptions have been issued through the NHS, the private market is expanding, with tens of thousands of patients benefiting from cannabis-based medicines.

In the country there are medical cannabis clinics and GMC specialist doctors who can prescribe this treatment. If the doctor considers the patient suitable, they issue a private prescription. The company states that medical cannabis can be prescribed for a range of health conditions with an unmet need, that is, when previous pharmaceutical medications have not worked or have not relieved symptoms: pain, psychiatric and mental health conditions such as anxiety and depression, neurological conditions such as spasticity and migraine, cancer patients, palliative care and children with severe epilepsy.

Pharmaceutical and regulatory details

The company operates as MHC Dispensary Ltd., trading as Botanical Health Dispensary. Its GPhC Premises Number is 9013028 and its Superintendent Pharmacist is Caroline Harvey, with GPhC registration number 2044315. The website includes a link to check the registration of pharmacists and pharmacies.

Location and contact

MHC Dispensary Ltd. Camden House Warwick Road Kenilworth CV8 1TH